David Hinkle
Net worth: 145 $ as of 2026-05-30
Net worth: 145 $ as of 2026-05-30
David A. Hinkle is currently Treasurer, Senior VP-Finance & Controller at Boundless Bio, Inc. since 2024.
Former positions include Vice President-Finance & Controller at Crinetics Pharmaceuticals, Inc. from 2018 to 2021, CAO, Finance Director & Controller at Receptos LLC, and Vice President & Controller at REMEC, Inc. Education includes undergraduate studies at California State University-Northridge.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-01-22 | 100 ( 0% ) | 145 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| BOUNDLESS BIO, INC. | Director of Finance/CFO | 2021-05-31 |
| Companies | Position | End |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2021-04-30 |
| RECEPTOS INC | Director of Finance/CFO | 2014-11-30 |
REMEC, Inc.
REMEC, Inc. Telecommunications EquipmentElectronic Technology Designs and makes microwave multi-function modules for microwave transmission systems | Comptroller/Controller/Auditor | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
REMEC, Inc.
REMEC, Inc. Telecommunications EquipmentElectronic Technology Designs and makes microwave multi-function modules for microwave transmission systems | Electronic Technology |
Receptos LLC
Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
California State University-Northridge
California State University-Northridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Boundless Bio, Inc.
Boundless Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops cancer therapeutics | Health Technology |
Select your edition
All financial news and data tailored to specific country editions